Literature DB >> 2230148

Efficient hybridization of mouse-human cell lines by means of hypo-osmolar electrofusion.

U Zimmermann1, P Gessner, R Schnettler, S Perkins, S K Foung.   

Abstract

The fusion of a mouse-human heteromyeloma with a mouse hybridoma is used as a model to define parameters to generate human hybridomas. Electrofusion of these cells in 300 mosM and 75 mosM solutions showed that strong hypo-osmolar conditions resulted in a dramatic increase in the efficiency of hybridoma formation. In contrast to iso-osmolar electrofusion, a high hybrid yield could be obtained by injection of only a single field pulse. The field strength was adjusted in proportion to the increased size of the cells in hypo-osmolar solutions. Hypo-osmolar electrofusion allowed the generation of approximately 0.45% hybrids at a suspension density of 1.75 X 10(5) mouse-human cells/ml corresponding to an input number of 3.5 X 10(4) mouse-human cells. A further increase in the efficiency of hybridoma formation to about 0.6% was achieved by cell alignment in an alternating field of modulated field strength. Experiments in which the total cell number per fusion chamber was decreased at constant optimum suspension density showed that a further increase in the efficiency of hybridoma formation in hypo-osmolar solution was not possible because of the increasing influence of the heterogeneity of the cell lines with decreasing cell number. The results allow the conclusion that hypo-osmolar electrofusion is a potential tool to enhance successful immortalisation of human B lymphocytes.

Entities:  

Mesh:

Year:  1990        PMID: 2230148     DOI: 10.1016/0022-1759(90)90110-h

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Manipulating the genetic identity and biochemical surface properties of individual cells with electric-field-induced fusion.

Authors:  A Strömberg; F Ryttsén; D T Chiu; M Davidson; P S Eriksson; C F Wilson; O Orwar; R N Zare
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  The systematic study of the electroporation and electrofusion of B16-F1 and CHO cells in isotonic and hypotonic buffer.

Authors:  Marko Usaj; Masa Kanduser
Journal:  J Membr Biol       Date:  2012-07-29       Impact factor: 1.843

3.  Hypotonically induced changes in the plasma membrane of cultured mammalian cells.

Authors:  V L Sukhorukov; W M Arnold; U Zimmermann
Journal:  J Membr Biol       Date:  1993-02       Impact factor: 1.843

4.  Surviving high-intensity field pulses: strategies for improving robustness and performance of electrotransfection and electrofusion.

Authors:  V L Sukhorukov; R Reuss; D Zimmermann; C Held; K J Müller; M Kiesel; P Gessner; A Steinbach; W A Schenk; E Bamberg; U Zimmermann
Journal:  J Membr Biol       Date:  2005-08       Impact factor: 1.843

5.  DNA, protein, and plasma-membrane incorporation by arrested mammalian cells.

Authors:  V L Sukhorukov; C S Djuzenova; W M Arnold; U Zimmermann
Journal:  J Membr Biol       Date:  1994-10       Impact factor: 1.843

6.  Efficient production of IgG human monoclonal antibodies by lymphocytes stimulated by lipopolysaccharide, pokeweed mitogen, and interleukin 4.

Authors:  K Yoshinari; K Arai; H Kimura; K Matsumoto; Y Yamaguchi
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

7.  An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.

Authors:  Xiaocong Yu; Patricia A McGraw; Frances S House; James E Crowe
Journal:  J Immunol Methods       Date:  2008-05-05       Impact factor: 2.303

8.  Relationship between antibody productivity by activated human lymph node lymphocytes from lung cancer patients and lymphocyte subsets.

Authors:  K Yoshinari; K Arai; K Matsumoto; H Kimura
Journal:  Cytotechnology       Date:  1999-05       Impact factor: 2.058

9.  Generation of human monoclonal antibodies recognising membranous antigens of the lung adenocarcinoma cell line A549 using an AMeX immunohistostaining method.

Authors:  K Yoshinari; H Kimura; K Arai; I Sugawara; K Noda; M Kihara; H Misaki; Y Yamaguchi
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

10.  Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodies.

Authors:  Girja S Shukla; Walter C Olson; Stephanie C Pero; Yu-Jing Sun; Chelsea L Carman; Craig L Slingluff; David N Krag
Journal:  J Transl Med       Date:  2017-08-29       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.